VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BTSGBrightSpring Health Services, Inc. Common Stock
$68.98$13.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksBTSGBalance Sheet

BrightSpring Health Services, Inc. Common Stock (BTSG) Balance Sheet

7Y historyFree accessUpdated daily

The company has significantly improved its financial stability by reducing total debt from $3.7 billion in 2023Q4 to $254.8 million in 2026Q1, resulting in a current debt-to-equity ratio of 0.13.

BTSG Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19
Total Current Assets2.69B2.89B1.89B1.46B1.34B1.18B1.29B870.68M
Cash & Short-Term Investments888.8M88.37M61.25M13.07M13.63M46.73M262M18.3M
Cash Only888.8M88.37M61.25M13.07M13.63M46.73M262M18.3M
Short-Term Investments00000000
Accounts Receivable1.11B989.72M1.15B1.01B868.35M805M700.84M622.28M
Days Sales Outstanding28.5827.9837.2341.841.0543.8745.8450.19
Inventory560.17M815.18M640.57M402.78M430.52M299.22M300.06M198.47M
Days Inventory Outstanding20.126.1224.1619.8924.6820.0424.1719.63
Other Current Assets126.81M1B24.59M13.19M13.51M12.66M16.41M23.37M
Total Non-Current Assets3.52B3.52B4.03B4.08B4.1B4.33B3.25B2.95B
Property, Plant & Equipment375.22M376.32M500.03M513.35M475.27M524.64M450.71M432.55M
Fixed Asset Turnover38.22x34.31x22.53x17.19x16.24x12.77x12.38x10.46x
Goodwill2.53B2.55B2.67B2.61B2.58B2.66B1.67B1.41B
Intangible Assets536.88M557.55M811.48M881.48M975.86M1.11B1.1B1.07B
Long-Term Investments14.54M0670K720K736K2.66M2.48M2.37M
Other Non-Current Assets78.35M39.71M43.8M72.12M68.93M35.78M32.22M34.56M
Total Assets6.21B6.41B5.93B5.53B5.44B5.51B4.54B3.82B
Asset Turnover2.22x2.01x1.90x1.60x1.42x1.21x1.23x1.19x
Asset Growth %25.08%8.22%7.11%1.68%-1.31%21.41%18.96%-
Total Current Liabilities1.55B1.85B1.43B1.25B932.51M892.16M742.79M621.97M
Accounts Payable1.09B1.22B941.29M641.61M526.92M408.11M355.75M252.75M
Days Payables Outstanding32.239.0235.531.6830.2127.3328.6524.99
Short-Term Debt105.09M102.07M48.73M32.27M30.41M40.54M22.5M18.48M
Deferred Revenue (Current)16.53M011M30.85M29.04M10.49M22.76M3.31M
Other Current Liabilities351.89M529.02M98.84M118.14M80.73M95.87M16.18M14.19M
Current Ratio1.74x1.57x1.33x1.17x1.44x1.32x1.74x1.40x
Quick Ratio1.38x1.12x0.88x0.84x0.98x0.99x1.33x1.08x
Cash Conversion Cycle16.4815.0825.8930.0135.5336.5741.3544.83
Total Non-Current Liabilities2.68B2.68B2.85B3.67B3.72B3.82B3.06B2.49B
Long-Term Debt149.75M2.59B2.56B3.33B3.36B3.39B2.67B2.16B
Capital Lease Obligations429.92M149.96M212.6M224.18M204.91M252.09M211.95M190.15M
Deferred Tax Liabilities17.79M6.18M023.67M79.39M98.16M121.64M65.68M
Other Non-Current Liabilities2.52B-68.86M71.76M91.94M75.94M77.04M57.98M65.46M
Total Liabilities4.22B4.53B4.27B4.92B4.66B4.71B3.81B3.11B
Total Debt254.83M2.84B2.9B3.67B3.68B3.77B2.97B2.44B
Net Debt-633.96M2.75B2.84B3.66B3.66B3.72B2.71B2.43B
Debt / Equity0.13x1.51x1.76x5.99x4.69x4.71x4.04x3.44x
Debt / EBITDA0.45x4.97x7.07x10.50x9.39x8.70x8.58x11.20x
Net Debt / EBITDA-1.11x4.81x6.92x10.46x9.35x8.59x7.82x11.12x
Interest Coverage2.13x2.59x0.85x0.45x0.80x1.42x1.19x0.38x
Total Equity1.98B1.89B1.65B612.55M784.08M800.46M735.38M710.23M
Equity Growth %52.46%14.22%169.63%-21.88%-2.05%8.85%3.54%-
Book Value per Share8.948.588.563.584.584.684.304.15
Total Shareholders' Equity1.98B1.88B1.65B584.74M754.78M774.82M704.98M656.87M
Common Stock1.93M1.92M1.74M1.18M1.18M1.18M745.17M745.88M
Retained Earnings14.13M-74.65M-222.16M-200.32M-45.72M971K-51.75M-94.28M
Treasury Stock00000000
Accumulated OCI-1.26M-6.69M1.42M12.54M21.19M217K185K132K
Minority Interest10.51M11.3M3.73M27.81M29.31M25.65M30.39M53.36M

Key Metrics

Growth RegimeExpanding
ProfitabilityStrained
Balance SheetMixed
Cash FlowImproving
Top Statement Risk

High leverage and goodwill

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Deleveraging Trend Improves Financial Stability

According to recent quarterly filings, BrightSpring has significantly reduced its total debt from $3.7 billion in 2023Q4 to $254.8 million by 2026Q1, signaling a material shift in the company's capital structure as it transitions from private equity-backed expansion toward a more sustainable public market profile.

The dramatic reduction in debt levels suggests a concerted effort to improve the balance sheet, which was previously burdened by high leverage ratios. This trajectory indicates that the company is prioritizing financial flexibility, though investors should monitor whether this deleveraging is sustainable given the thin net margins.

Rapid Debt Reduction Enhances Solvency

As reported in financial statements, the debt-to-equity ratio plummeted from 5.99 in 2023Q4 to 0.13 in 2026Q1, reflecting a substantial improvement in the company's leverage profile that may reduce interest expense volatility and enhance the durability of future cash flows.

The sharp decline in debt suggests that the company has successfully utilized capital to pay down obligations, likely following its public listing. This shift significantly lowers the risk of insolvency, although the company must now demonstrate that it can maintain this lower leverage while continuing to fund its operational requirements.

Goodwill Dominates Asset Composition

Based on the company's reported figures, goodwill accounts for approximately $2.5 billion of the $6.2 billion total assets as of 2026Q1, indicating that the firm's asset base is heavily reliant on past acquisitions rather than tangible property, plant, or equipment.

The high concentration of goodwill suggests that the company's valuation is sensitive to potential impairment charges if acquired businesses fail to meet performance expectations. This asset mix highlights the risks inherent in a roll-up strategy, where the value of the enterprise is tied to intangible synergies.

Liquidity Buffer Strengthens Amid Operations

As indicated by the latest quarterly data, the current ratio has improved to 1.74 in 2026Q1 from a low of 1.17 in 2023Q4, providing a more robust buffer against short-term operational shocks and potential delays in government reimbursement cycles.

The improvement in liquidity appears to be driven by a significant increase in cash reserves, which reached $888.8 million in the most recent quarter. This enhanced cash position provides the company with greater flexibility to manage working capital volatility and fund ongoing clinical service requirements.

Retained Earnings Turn Positive

According to the balance sheet data, retained earnings shifted from a deficit of $200.3 million in 2023Q4 to a positive $14.1 million in 2026Q1, marking a critical milestone in the company's transition toward generating sustainable shareholder value.

This reversal in retained earnings suggests that the company is beginning to retain profits rather than solely relying on external financing or equity dilution. While the amount remains modest, it indicates a potential inflection point in the company's ability to self-fund its growth initiatives.

BTSG — Frequently Asked Questions

Quick answers to the most common questions about buying BTSG stock.

What are the total assets of BrightSpring Health Services, Inc. Common Stock (BTSG)?

As of 2025, BrightSpring Health Services, Inc. Common Stock (BTSG) had total assets of $6.41B including $2.89B in current assets.

How much debt does BrightSpring Health Services, Inc. Common Stock (BTSG) have?

BrightSpring Health Services, Inc. Common Stock (BTSG) carries total debt of $2.84B, offset by $88.4M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of BrightSpring Health Services, Inc. Common Stock?

BrightSpring Health Services, Inc. Common Stock (BTSG) has total shareholders' equity (book value) of $1.88B ($8.58 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is BrightSpring Health Services, Inc. Common Stock's current ratio and liquidity?

BrightSpring Health Services, Inc. Common Stock (BTSG) reported a current ratio of 1.57x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.